Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide
Curr Med Res Opin. 2014 May;30(5):931-6
Once-weekly teriparatide reduces vertebral fracture risk: Subgroup analysis from the Teriparatide Once Weekly Efficacy Research (TOWER) trial